Sol-Gel Technologies (SLGL) EPS (Basic) (QoQ) (2018 - 2026)

Sol-Gel Technologies (SLGL) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Sol-Gel Technologies 240.26 Mn 230.12 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 105.91%
Dec 31, 2025 -884.62%
Sep 30, 2025 -150,791,466.91%
Jun 30, 2025 -100.00%
Mar 31, 2025 115.76%
Dec 31, 2024 -6,649.88%
Sep 30, 2024 -116,619,818.31%
Jun 30, 2024 -100.00%
Mar 31, 2024 111.57%
Dec 31, 2023 -859.72%
Sep 30, 2023 -2,578,766,102.14%
Jun 30, 2023 -100.00%
Mar 31, 2023 3,976,280,089.83%
Dec 31, 2022 -66.67%
Sep 30, 2022 -1,599.93%
Jun 30, 2022 -100.00%
Mar 31, 2022 915,002,195.97%
Dec 31, 2021 918.16%
Sep 30, 2021 -82.91%
Jun 30, 2021 -100.00%